Mycobacterium tuberculosis subverts innate immunity to evade specific effectors.

Détails

ID Serval
serval:BIB_EF9D927AC4DD
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Mycobacterium tuberculosis subverts innate immunity to evade specific effectors.
Périodique
Journal of Immunology
Auteur⸱e⸱s
Loeuillet C., Martinon F., Perez C., Munoz M., Thome M., Meylan P.R.
ISSN
0022-1767[print], 0022-1767[linking]
Statut éditorial
Publié
Date de publication
2006
Volume
177
Numéro
9
Pages
6245-6255
Langue
anglais
Résumé
The macrophage is the niche of the intracellular pathogen Mycobacterium tuberculosis. Induction of macrophage apoptosis by CD4(+) or CD8(+) T cells is accompanied by reduced bacterial counts, potentially defining a host defense mechanism. We have already established that M. tuberculosis-infected primary human macrophages have a reduced susceptibility to Fas ligand (FasL)-induced apoptosis. To study the mechanisms by which M. tuberculosis prevents apoptotic signaling, we have generated a cell culture system based on PMA- and IFN-gamma-differentiated THP-1 cells recapitulating the properties of primary macrophages. In these cells, nucleotide-binding oligomerization domain 2 or TLR2 agonists and mycobacterial infection protected macrophages from apoptosis and resulted in NF-kappaB nuclear translocation associated with up-regulation of the antiapoptotic cellular FLIP. Transduction of a receptor-interacting protein-2 dominant-negative construct showed that nucleotide-binding oligomerization domain 2 is not involved in protection in the mycobacterial infection system. In contrast, both a dominant-negative construct of the MyD88 adaptor and an NF-kappaB inhibitor abrogated the protection against FasL-mediated apoptosis, showing the implication of TLR2-mediated activation of NF-kappaB in apoptosis protection in infected macrophages. The apoptosis resistance of infected macrophages might be considered as an immune escape mechanism, whereby M. tuberculosis subverts innate immunity signaling to protect its host cell against FasL(+)-specific cytotoxic lymphocytes.
Mots-clé
Apoptosis/immunology, Apoptosis Regulatory Proteins/genetics, Apoptosis Regulatory Proteins/metabolism, Cell Line, Tumor, Cell Nucleus/chemistry, Cell Wall, Fas Ligand Protein/pharmacology, Humans, Immune Tolerance, Immunity, Innate, Macrophages/drug effects, Macrophages/immunology, Models, Biological, Mycobacterium tuberculosis/immunology, NF-kappa B/agonists, NF-kappa B/analysis, Nod2 Signaling Adaptor Protein/antagonists &amp, inhibitors, Nod2 Signaling Adaptor Protein/genetics, Peptidoglycan/pharmacology, Signal Transduction, Toll-Like Receptor 2/agonists, Toll-Like Receptor 2/physiology
Pubmed
Web of science
Création de la notice
24/01/2008 16:11
Dernière modification de la notice
20/08/2019 17:17
Données d'usage